FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Pfizer | DTC advertising | Merck | Stupak

DTC hearing has high-powered guest list

Tools

Hail, hail the gang's all here...at the House Subcommittee on Oversight and Investigations hearing on direct-to-consumer ads. Next week, Rep. Bart Stupak will preside over testimony from Pfizer, Merck, Schering-Plough, and Johnson & Johnson. Kaiser Permanente, the GAO, and the AMA may be there, too.

The official title of the hearing? "Direct-to-Consumer Advertising: Marketing, Education, or Deception?' Not surprising, considering Stupak's history as an industry critic, but definitely not comfortable for those scheduled to say their piece. If you're interested, the committee will offer a video feed.

- see the Pharmalot item
- get the link to the webcast at the committee's site

Related Articles:
Study: Drug ads drown in online noise
To DTC or not to DTC?
Should FDA's info be in all DTC ads?
FDA to study TV drug ad imagery
Survey: No doubt DTC ads work


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:

More stories about Pfizer   DTC advertising   Merck   Stupak